Philippines News Headline January 21, 2022 Under One Ceiling 0 Polish researchers invent anti-smog sound cannon 0 0000 0 0 more Polish researchers invent anti-smog sound cannon January 21, 2022 Under One Ceiling now playing Transferring money from UAE abroad: what are my cheapest options January 21, 2022 Under One Ceiling WIN With Nespresso This Mother’s Day January 21, 2022 Under One Ceiling NBA Playoffs 2022: A Casual Fan's Guide to the Postseason January 21, 2022 Under One Ceiling Best New Climbing Gear of 2022 January 21, 2022 Under One Ceiling A Local Weekend Travel Guide to Austin, Texas January 21, 2022 Under One Ceiling First Drive: 2022 Range Rover Ups the Luxury SUV Experience January 21, 2022 Under One Ceiling Most Stylish Rain Jackets, Parkas, and Trench Coats for Men January 21, 2022 Under One Ceiling EU eyes Russian oil import ban as Moscow strikes western Ukraine January 21, 2022 Under One Ceiling World-class Clark Int’l Airport opens new 110,000 square-meter passenger terminal January 21, 2022 Under One Ceiling PCG: Bodies of 5 children who drowned in Taal Lake found January 21, 2022 Under One Ceiling Polish researchers invent anti-smog sound cannon KALWARIA ZEBRZYDOWSKA, Poland (AFP) – In a battle against Poland’s constant smog, scientists are testing out a new “cannon” that uses soundwaves to push toxic particles higher into the atmosphere to allow residents to breathe. Installed on top of a metal container, the experimental device consists of a large upside-down cone that makes a loud sound every six seconds. The aim is to chase the smog from Kalwaria Zebrzydowska, which like many Polish towns and cities […] Related Related posts: Aboitiz Foundation donates surgical masks to MMDA ‘Down’ but not ‘out’: Growth needs fuel India’s coal addiction Russian flagship sinks after Kyiv claims missile hit tags: Philippines News RSS Feed 0000 0 0 previous Kalinga, Ifugao, Mountain Province, Northern Samar under COVID-19 alert level 4 until Jan. 31 next DOST: Lagundi proven effective in relieving symptoms in mild COVID-19 based on latest clinical trial results
